Why hasn't any pharmaceutical companies come out with something comparable to Drixoral? There's a whole bunch of us feeling really nauseated and tired without our Drixoral!!!!
Q: I am allergic to ALL other OTC, besides Drixoral. Any suggestions?
Answers (1)
7/12/08 9:24pm
Hi Joanne,
As you know Drixoral has been a hot topic on this website for several weeks. I have discussed this issue with pharmaceutical reps that come to my office to provide information and samples of other Schering drugs (Clarinex, Nasonex etc.).
I recently received an email from another Schering official that confirmed the halt on production of Drixoral. It may come back but there is no established timetable for the return of Drixoral . Whether it will be re-formulated with a substitute for the pseudoephedrine component was not stated (but I suspect it will, if it comes back).
In the mean time here are two hyperlinks that provide more food for thought.
Best to you,
J. Thompson, MD.
Important:
We hope you find this general health information helpful. Please note however, that this Q&A is meant to support not replace the professional medical advice you receive from your doctor. No information in the Answers above is intended to diagnose or treat any condition. The views expressed in the Answers above belong to the individuals who posted them and do not necessarily reflect the views of The HealthCentral Network. The HealthCentral Network does not review or edit content posted by our community members, but reserves the right to remove any material it deems inappropriate.
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
